Business● Low29m ago · Nov 10, 2026, 10:26 AM
ArriVent BioPharma GAAP EPS of -$0.81
GlobeAlert Desk · curated from Seeking Alpha Tech · global
ArriVent BioPharma reported GAAP EPS of -$0.81, providing an update on its financial performance. This information is relevant for investors and market analysts.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business23m agoInflation report to provide 1st snapshot of prices since midterm electionsABC NewsBusiness25m agoSummit Midstream GAAP EPS of $0.58 beats by $0.46, revenue of $183M beats by $24.4MSeeking Alpha TechBusiness26m agoSecuritize to buy River Credit LabsSeeking Alpha TechBusiness31m agoBrent Drops Below $90 On US-Iran Peace HopesChannels TV